Literature DB >> 15187861

Increased intercellular communication through gap junctions may contribute to progression of osteoarthritis.

Andrew A Marino1, David D Waddell, Oleg V Kolomytkin, William D Meek, Robert Wolf, Kalia K Sadasivan, James A Albright.   

Abstract

Our aim was to support the hypothesis of a specific association between gap junctions in synovial tissue and the presence of osteoarthritis, as evidenced by differences between osteoarthritis and non-osteoarthritis synovia in the number of gap junctions, the amount of gap-junction protein, and the amount of enzymatic activity produced through a pathway mediated by gap-junction intercellular communication. An average of 4.41 gap junctions were found per 100 cells counted in the osteoarthritis synovia, compared with 1.00 in the controls. The amount of the gap-junction protein connexin 43 in synovial lining cells was approximately 50% greater in patients with osteoarthritis. Synovial lining cells from patients with osteoarthritis produced matrix metalloproteinases constitutively and, at higher levels, in response to stimulation by interleukin-1 beta. In both cases, intercellular communication through gap junctions was shown to be critical to the ability of the cells to secrete matrix metalloproteinases. Overall, the results indicated that gap junctions between synovial lining cells were altered significantly in patients with osteoarthritis, as a consequence of the disease process or as part of the causal chain. In either case, gap junctions seem to be a rational therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187861     DOI: 10.1097/01.blo.0000129346.29945.3b

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

Review 1.  Genetics of susceptibility and treatment response in psoriatic arthritis.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Nat Rev Rheumatol       Date:  2011-11-08       Impact factor: 20.543

2.  Fibroblast-like synoviocyte mechanosensitivity to fluid shear is modulated by interleukin-1α.

Authors:  Eben G Estell; Lance A Murphy; Amy M Silverstein; Andrea R Tan; Roshan P Shah; Gerard A Ateshian; Clark T Hung
Journal:  J Biomech       Date:  2017-06-28       Impact factor: 2.712

Review 3.  Joint diseases: from connexins to gap junctions.

Authors:  Henry J Donahue; Roy W Qu; Damian C Genetos
Journal:  Nat Rev Rheumatol       Date:  2017-12-19       Impact factor: 20.543

4.  Viscosupplementation with hylan g-f 20 in patients with osteoarthrosis of the knee.

Authors:  Jack M Bert; David D Waddell
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

5.  Identification of shoulder osteoarthritis biomarkers: comparison between shoulders with and without osteoarthritis.

Authors:  Danielle Casagrande; Joseph P Stains; Anand M Murthi
Journal:  J Shoulder Elbow Surg       Date:  2015-01-13       Impact factor: 3.019

Review 6.  Connexins and pannexins in the skeleton: gap junctions, hemichannels and more.

Authors:  Lilian I Plotkin; Joseph P Stains
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

7.  Interleukin-1beta increases gap junctional communication among synovial fibroblasts via the extracellular-signal-regulated kinase pathway.

Authors:  Corinne Niger; Floyd D Howell; Joseph P Stains
Journal:  Biol Cell       Date:  2009-10-12       Impact factor: 4.458

8.  Connexin43 Mediated Delivery of ADAMTS5 Targeting siRNAs from Mesenchymal Stem Cells to Synovial Fibroblasts.

Authors:  Shuo Liu; Corinne Niger; Eugene Y Koh; Joseph P Stains
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 9.  Role of connexins and pannexins during ontogeny, regeneration, and pathologies of bone.

Authors:  Lilian I Plotkin; Dale W Laird; Joelle Amedee
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

10.  Connexin43 enhances the expression of osteoarthritis-associated genes in synovial fibroblasts in culture.

Authors:  Aditi Gupta; Corinne Niger; Atum M Buo; Eric R Eidelman; Richard J Chen; Joseph P Stains
Journal:  BMC Musculoskelet Disord       Date:  2014-12-11       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.